Trending Topic

virus closeup, contagious pathogen. Monkey pox virus closeup, contagious pathogen, infectious zoonotic disease
7 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as clade 2b.2 Comparatively, clade 1 leads to a more severe disease state and greater […]

Speciality Filter
Or View our Specialities Page

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive ...

Want to be featured in touchReviews in Infectious Diseases?

Share your knowledge, influence clinical practices and enhance patient care in Infectious Diseases today!

  • Peer-reviewed, free-to-access
  • Accepting reviews, research and editorials
  • No article processing fees
  • Digital features and plain language summaries
  • Multichannel content distribution for maximum visibility
  • Submit an Article

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore how point-of-care testing is transforming the management of sexually transmitted infections (STIs). Joined by Dr Libby van Gerwen, we discuss the rising global STI rates and the role these innovative tests play in addressing the issue. We also explore the challenges current point-of-care tests face and how next-generation advancements could further transform the future of STI diagnosis and treatment.

Mark CompleteCompleted
BookmarkBookmarked
Grace Johanna Salazar Tamayo

Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control ...

38 mins
touchIN CONVERSATION
Mark CompleteCompleted
BookmarkBookmarked

Two experts discuss best practices for antiretroviral therapy (ART) selection for people living with HIV.

38 mins
touchEXPERT OPINIONS
Mark CompleteCompleted
BookmarkBookmarked
Prof. Anne-Mieke Vandamme, Prof. José Arribas, Prof. Antonella Castagna

Watch three experts describe the HIV life cycle, the rationale for ART and how to manage ART resistance.

Mark CompleteCompleted
BookmarkBookmarked

The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1 Currently, there are an estimated 30 million people on antiretroviral treatment for HIV ...

Mark CompleteCompleted
BookmarkBookmarked

Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1 Worldwide, RSV is the second leading cause of death (second to malaria) in children during ...

Mark CompleteCompleted
BookmarkBookmarked

Vaginal symptoms are one of the most common reasons for women accessing acute healthcare in the USA.1 Vaginitis is most commonly evaluated based on clinical observations, including assessment of discharge characteristics, vaginal pH and, in some settings, microscopic examination of ...

Mark CompleteCompleted
BookmarkBookmarked

We are excited to introduce the latest edition of touchREVIEWS in Infectious Diseases. Our mission is to bring you thought-provoking interviews, reviews, editorials, case studies and original research within the realm of infectious diseases. We aspire to engage infectious disease ...

Mark CompleteCompleted
BookmarkBookmarked

The treatment of people with HIV (PWH)/hepatitis B virus (HBV) co-infection, especially those who have additional comorbidities requiring multiple drug therapies can be problematic. Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is a co-formulated medication consisting of two components ...

Mark CompleteCompleted
BookmarkBookmarked

By sharing, listening and gaining an understanding of the real-life experiences of individuals living with a condition, clinicians and patients can better work together to improve care and outcomes and shape the healthcare system and policy of the future. Patient ...

Mark CompleteCompleted
BookmarkBookmarked

Despite being the most severe form of viral hepatitis, there is no FDA-approved therapy for chronic hepatitis delta (CHD).1 Patients with CHD can progress to cirrhosis, as early as 5–10 years after infection. Further complications can also develop, such as esophageal ...

Mark CompleteCompleted
BookmarkBookmarked

Article highlights Erythrasma is a common chronic superficial cutaneous bacterial infection caused by Corynebacterium minutissimum when conditions are conducive. Corynebacterium minutissimum produces coproporphyrin III (a phosphor) that emits a coral pink fluorescence under Wood’s lamp and helps confirm the ...

Load More...

Editorial Board

Introducing the Editorial Board of touchREVIEWS in Infectious Diseases, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.

View All Members

Nyuma Mbewe

Editorial Board Member

HIV and Policy

Close Popup

Nyuma Mbewe

Editorial Board Member

Infectious Diseases Physician, General Practitioner, Ministry of Health of Zambia, Africa

Case Management Specialist, Zambia National Public Health Institute, Zambia, Africa

Zambia, Africa

Biography

Dr Nyuma Mbewe is a specialist in Internal Medicine and Infectious Diseases (Mmed-ID)

Dariusz Hareza

Dariusz Hareza

Dariusz Hareza

Dariusz Hareza

Antimicrobial Resistance

Close Popup

Dariusz Hareza

Dariusz Hareza

Assistant Professor of Medicine (Infectious Diseases), Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Chicago, IL, USA

Biography

Dr Dariusz Hareza is Assistant Professor of Medicine (Infectious Diseases) at the Northwestern University Feinberg School of Medicine, Chicago, IL, USA. He is working with mentors to research antimicrobial resistance (AMR). He is also a fellow at the NIH-funded Antibacterial Resistance Leadership Group (ARLG) and recently finished an infectious diseases fellowship at Johns Hopkins University, Baltimore, MD, USA, where he received a master’s degree in clinical investigation. His research involves the molecular epidemiology and clinical outcomes in extended-spectrum beta-lactamase producing Enterobacterales and difficult-to-treat Pseudomonas aeruginosa.

Nyuma Mbewe

Editorial Board Member

Amesika Nyaku

Editor-in-Chief

Amesika Nyaku

Editor-in-Chief

HIV

Close Popup

Amesika Nyaku

Editor-in-Chief

Assistant Professor, Division of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA

Newark, NJ, USA

Biography

Amesika Nyaku, MD MS is an Assistant Professor in the Division of Infectious Diseases at Rutgers New Jersey Medical School and a physician-scientist. She provides clinical care for people living with HIV or other infectious diseases and substance use disorders. Her research interests lie at the intersection of HIV and substance use disorders. She focuses on 1) evaluating long-acting therapeutics for HIV and opioid use disorder, 2) the implementation of integrated care models for HIV and substance use disorders to improve health outcomes, and 3) increasing the inclusion and participation of racial/ethnic minorities in clinical trials research. She is also co-director of the Northern New Jersey Medication-Assisted Treatment Center of Excellence that is tasked with assisting the state in expanding access to medication-assisted treatment for opioid use disorder through education, novel service delivery and community collaboration.

Dariusz Hareza

Dariusz Hareza

Jon Salmanton-García

Editorial Board Member

Jon Salmanton-García

Editorial Board Member

Fungal & Respiratory Infections

Close Popup

Jon Salmanton-García

Editorial Board Member

Postdoctoral Researcher and Project Manager, University Hospital of Cologne, Cologne, Germany

Cologne, Germany

Biography

Dr. Jon Salmanton-García is a researcher specializing in infectious diseases in immunocompromised patients, with a particular focus on respiratory viral infections in hematology and fungal diseases. He holds a PhD in Health Sciences from the University of Cologne and has published numerous scientific articles while presenting his work at national and international congresses. He serves as the scientific coordinator of the EPICOVIDEHA registry, which investigates respiratory viral infections in hematological patients, and leads the Diagnostic and Treatment Capacity of Invasive Fungal Infections initiative. Additionally, he has held leadership roles in European medical associations, contributing to advances in infection management for vulnerable populations.

Amesika Nyaku

Editor-in-Chief

Ikechukwu Benjamin Moses

Editorial Board Member
Advertisement
  • touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

    Register Now!

    Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

    • Save your progress for video
    • Keep track of your CME credits
    • Add personalised learning notes
    • Receive updates from course leaders and faculty
    • Be the first to hear about new and exciting interactive learning opportunities
    Close Popup